These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37323046)

  • 1. [Prevention and treatment of antipsychotic induced weight gain].
    Veerman SRT; Cohen D
    Tijdschr Psychiatr; 2023; 65(4):259-265. PubMed ID: 37323046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological interventions for antipsychotic-induced weight gain in schizophrenia: A network meta-analysis.
    Hegde NC; Mishra A; Maiti R; Mishra BR; Mohapatra D; Srinivasan A
    Gen Hosp Psychiatry; 2024; 90():12-21. PubMed ID: 38878592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial.
    de Boer N; Guloksuz S; van Baal C; Willebrands L; Deenik J; Vinkers CH; Rossum IW; Zinkstok J; Wilting I; Zantvoord JB; Backx F; Swildens WE; Schouw M; Bogers J; Hulshof F; de Knijff R; Duindam P; Veereschild M; Bak M; Frederix G; de Haan L; van Os J; Cahn W; Luykx JJ
    BMC Psychiatry; 2021 Jan; 21(1):4. PubMed ID: 33402159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
    Ellinger LK; Ipema HJ; Stachnik JM
    Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological Interventions of Atypical Antipsychotics Induced Weight Gain in the Pediatric Population: A Systemic Review of Current Evidence.
    Al Jumaili W; Muzwagi A; Shah K; Trivedi C; Durga P; Mansuri Z; Jain S; Al Jumaili Y
    Child Psychiatry Hum Dev; 2024 Apr; 55(2):479-487. PubMed ID: 36066654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the -2548G/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysis.
    Yoshida K; Maciukiewicz M; Zai CC; Gonçalves VF; Brandl EJ; Lieberman JA; Meltzer HY; Tiwari AK; Kennedy JL; Müller DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Aug; 102():109952. PubMed ID: 32335267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment.
    Raben AT; Marshe VS; Chintoh A; Gorbovskaya I; Müller DJ; Hahn MK
    Front Neurosci; 2017; 11():741. PubMed ID: 29403343
    [No Abstract]   [Full Text] [Related]  

  • 8. Metformin in the management of antipsychotic-induced weight gain in adults with psychosis: development of the first evidence-based guideline using GRADE methodology.
    Fitzgerald I; O'Connell J; Keating D; Hynes C; McWilliams S; Crowley EK
    Evid Based Ment Health; 2022 Feb; 25(1):15-22. PubMed ID: 34588212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis.
    Barton BB; Segger F; Fischer K; Obermeier M; Musil R
    Expert Opin Drug Saf; 2020 Mar; 19(3):295-314. PubMed ID: 31952459
    [No Abstract]   [Full Text] [Related]  

  • 10. A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia.
    Gonçalves VF; Zai CC; Tiwari AK; Brandl EJ; Derkach A; Meltzer HY; Lieberman JA; Müller DJ; Sun L; Kennedy JL
    Neuropsychopharmacology; 2014 May; 39(6):1347-54. PubMed ID: 24196945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipsychotic-Induced Weight Gain in Severe Mental Illness: Risk Factors and Special Considerations.
    Stogios N; Humber B; Agarwal SM; Hahn M
    Curr Psychiatry Rep; 2023 Nov; 25(11):707-721. PubMed ID: 37755655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis.
    Mizuno Y; Suzuki T; Nakagawa A; Yoshida K; Mimura M; Fleischhacker WW; Uchida H
    Schizophr Bull; 2014 Nov; 40(6):1385-403. PubMed ID: 24636967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide association study implicates lipid pathway dysfunction in antipsychotic-induced weight gain: multi-ancestry validation.
    Liao Y; Yu H; Zhang Y; Lu Z; Sun Y; Guo L; Guo J; Kang Z; Feng X; Sun Y; Wang G; Su Z; Lu T; Yang Y; Li W; Lv L; Yan H; Zhang D; Yue W
    Mol Psychiatry; 2024 Jun; 29(6):1857-1868. PubMed ID: 38336841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic validation study of protein tyrosine phosphatase receptor type D (PTPRD) gene variants and risk for antipsychotic-induced weight gain.
    Maciukiewicz M; Gorbovskaya I; Tiwari AK; Zai CC; Freeman N; Meltzer HY; Kennedy JL; Müller DJ
    J Neural Transm (Vienna); 2019 Jan; 126(1):27-33. PubMed ID: 30229349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans.
    Maciukiewicz M; Tiwari AK; Zai CC; Gorbovskaya I; Laughlin CP; Nurmi EL; Liebermann JA; Meltzer HY; Kennedy JL; Müller DJ
    Schizophr Res; 2019 Oct; 212():204-212. PubMed ID: 31447353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of SNAP25 variants with schizophrenia and antipsychotic-induced weight change in large-scale schizophrenia patients.
    Guan F; Zhang T; Han W; Zhu L; Ni T; Lin H; Liu D; Chen G; Xiao J; Li T
    Schizophr Res; 2020 Jan; 215():250-255. PubMed ID: 31653583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The positive association between antipsychotic-induced weight gain and therapeutic response: New biotypes of schizophrenia.
    Lu Z; Zhang Y; Sun Y; Liao Y; Kang Z; Feng X; Yan H; Li J; Wang L; Lu T; Zhang D; Huang Y; Yue W
    Psychiatry Res; 2023 Jun; 324():115226. PubMed ID: 37116323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic factors associated with amisulpride-induced weight gain in first-episode psychosis patients (from the OPTiMiSE cohort).
    Pandit R; Cianci D; Ter Hark SE; Winter-van Rossum I; Ebdrup BH; Broberg BV; Garcia-Portilla MP; Bobes J; Vinkers CH; Kahn RS; Guloksuz S; Huitema ADR; Luykx JJ
    Acta Psychiatr Scand; 2019 Sep; 140(3):283-290. PubMed ID: 31323113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of licensed weight-loss medications in treating antipsychotic-induced weight gain and obesity in schizophrenia and psychosis.
    Lee K; Abraham S; Cleaver R
    Gen Hosp Psychiatry; 2022; 78():58-67. PubMed ID: 35863294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.